These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 363599)

  • 1. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
    Scott DM; McConnell I; Agomo P; Lachmann PJ
    Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on guinea-pig macrophage migration inhibitory factor (MIF). I. Glycoprotein nature and net charge.
    Kotkes P; Pick E
    Clin Exp Immunol; 1979 Sep; 37(3):532-9. PubMed ID: 228883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed hypersensitivity reactions in guinea-pigs using cotton pellets; demonstration of macrophage migration inhibition activity in the cell free exudate.
    Yamamoto S; Ishikura A
    J Pathol; 1979 Jan; 127(1):1-10. PubMed ID: 381610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of antigen-dependent migration inhibition factor in mice.
    Hochova B; Krejcí J; Pekarek J; Svejcar J; Johanovsky J
    Immunology; 1975 Aug; 29(2):231-6. PubMed ID: 1098999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guinea pig macrophage agglutination factor is antigenically distinct from migration inhibition factor and immunoglobulin.
    Godfrey HP; Geczy CL
    J Immunol; 1978 Oct; 121(4):1428-31. PubMed ID: 359706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of immunoglobulin-bearing lymphocytes in the production of macrophage migration inhibitory factor.
    Pick E; Godny Y; Gold EF
    Eur J Immunol; 1975 Aug; 5(8):584-7. PubMed ID: 789092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on delayed hypersensitivity pleural exudates in guinea pigs. I. Demonstration of substances in the cell-free exudate which cause inhibition of mononuclear cell migration in vitro.
    Yamamoto S; Dunn CJ; Willoughby DA
    Immunology; 1976 Apr; 30(4):505-11. PubMed ID: 131779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on guinea-pig macrophage migration inhibitory factor (MIF). II. Purification of MIF after treatment with reducing and denaturing agents.
    Kotkes P; Pick E
    Clin Exp Immunol; 1979 Sep; 37(3):540-50. PubMed ID: 389497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
    Sorg C; Geczy CL
    Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial characterization of murine migration inhibitory factor (MIF).
    Kühner AL; David JR
    J Immunol; 1976 Jan; 116(1):140-5. PubMed ID: 1107423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. II. Production and characterization of an anti-MIF antibody.
    Fahlbusch B; Metzner G; Schumann I; Tittel R
    Biomed Biochim Acta; 1986; 45(3):371-84. PubMed ID: 3518711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the inhibition of macrophage migration induced by soluble antigen-antibody complexes.
    Kotkes P; Pick E
    Clin Exp Immunol; 1975 Jan; 19(1):105-20. PubMed ID: 54230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human polymorphonuclear leucocyte migration inhibitory factor. Evidence for antigen dependency.
    Weisbart RH; Isaacson J; Bluestone R; Goldberg LS
    Immunology; 1975 Aug; 29(2):223-30. PubMed ID: 50998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. I. Biochemical characterization and purification.
    Fahlbusch B; Tittel R
    Biomed Biochim Acta; 1986; 45(3):359-70. PubMed ID: 3518710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial purification of the cholestatic factor derived from the lymphocytes of tuberculin-sensitized guinea pigs.
    Mizoguchi Y; Ohnishi F; Monna T; Yamamoto S; Morisawa S
    Gastroenterol Jpn; 1981; 16(3):260-7. PubMed ID: 7021301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of MIF-like supernatants by rheumatoid arthritis lymphocytes stimulated by immunoglobulin G.
    Sany J; Mathieu O; Clot J; Mandin J; Serre H
    Rheumatology; 1975; 6():131-8. PubMed ID: 1105742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure.
    Nishihira J; Kuriyama T; Nishino H; Ishibashi T; Sakai M; Nishi S
    Biochem Mol Biol Int; 1993 Dec; 31(5):841-50. PubMed ID: 8136702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
    Cameron DJ
    J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse spleen cell-derived toxoplasma growth inhibitory factor: its separation from macrophage migration inhibitory factor.
    Nagasawa H; Igarashi I; Matsumoto T; Sakurai H; Marbella C; Suzuki N
    Immunobiology; 1980 Dec; 157(4-5):307-19. PubMed ID: 7005083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.